Common COVID-19 Treatment in Texas Under Recall Over Glass Particles
HOUSTON, Texas (KPEL News) - A widely used COVID-19 treatment medication is currently facing a nationwide recall, and patients in Texas should exercise caution regarding their injections.
The medication in question, Veklury—more commonly known as remdesivir—is a product manufactured by Gilead Sciences.
According to recent reports from the Food and Drug Administration (FDA), there have been troubling complaints about glass particles being found in 100 mg vials of the drug.
When it comes to administering any injectable medication, contamination with glass particles poses serious health risks. The FDA warns that injections containing glass fragments can trigger localized irritation or swelling as the body attempts to handle the foreign material. However, the risks don't stop there.
These microscopic glass particles can enter the bloodstream, potentially traveling to critical organs, such as the heart, lungs, or brain. If this happens, there’s a risk of severe complications, as the glass fragments could block blood vessels, leading to life-threatening issues like strokes or even death.
Despite the alarming potential dangers, Gilead has assured that, up to this point, there have been no reported cases of adverse effects connected to this recall.
Nevertheless, it’s essential for patients and healthcare providers to remain vigilant and informed about this situation.
The FDA says that Gilead is reaching out to its distributors and customers by sending UPS Next Day airmail to pharmacies, ensuring the swift return of any remaining vials from the affected lot of Veklury® (remdesivir) for Injection 100 mg/vial.
Below is a table laying out the details of the recall.
Product Description | NDC | Lot # | Expiration Date | Distribution Date to Wholesalers |
---|---|---|---|---|
Veklury® (remdesivir 100mg for injection) | 61958-2901-02 | 47035CFA | Exp. Date 11/2025 | 07/16/2024 to 08/07/2024 |
Healthcare facilities in possession of the recalled medicine should immediately cease using the affected batch and follow the return instructions provided in Gilead’s notification letter.
For any inquiries related to this recall, consumers and healthcare professionals can contact Gilead Medical Information at 1-866-633-4474, available Monday through Friday from 5 a.m. to 6 p.m. PST, or visit their website at www.askgileadmedical.com. If you have experienced any issues that might be connected to this medication, it’s advised to consult with your physician or healthcare provider promptly.
Most Wanted Texas Fugitives (September 2024)
Gallery Credit: Billy Jenkins